Novartis announced yesterday that it has launched an app specifically designed for eye patients to participate in ophthalmic clinical trials. Built with ResearchKit, the FocalView app looks to improve data captured by allowing patients interested in participating to conveniently self-report their conditions through their smartphone, thereby providing researchers with a greater wealth of time-stamped data.

from MobiHealthNews https://ift.tt/2FlDOJk

0 comments:

Post a Comment

Popular Posts